Citation: haydin s et al.Surgical strategies and results for repair of pulmonary atresia with ventricular septal defect and major a ortopulmonary collaterals: experience of a single tertiary center.Braz j cardiovasc surg.2020 aug 1;35(4):445-451.Doi: 10.21470/1678-9741-2019-0055.Earliest date of publish used for date of event.Medtronic products referenced: contegra conduit (pma# h020003, product code mwh), hancock conduit (pma# p790007, product code lwr).Earliest approved product used for product code and pma#.No unique device identifier (serial/lot) numbers were provided; without this information it could not be determined whether these observations have been previously reported.Without return of the product no definitive conclusion can be made regarding the clinical observations.If information is provided in the future, a supplemental report will be issued.
|
Medtronic received information from a literature article regarding the surgical management and outcomes of patients with pulmonary atresia and ventricular septal defect with major aortopulmonary collateral arteries.All data was retrospectively collected from a single center between january 2012 and october 2018.The study population included 36 patients and was predominantly male with a median age of 5.5 months and a median weight of 8 kg.In 14 of these patients, the right ventricle to pulmonary artery (rv-pa) connection was preserved with the implant of a medtronic valved conduit: contegra (13) or hancock (1).No serial numbers were provided.Among all patients, seven deaths occurred (3 in-hospital, 4 during follow-up).Multiple manufacturers devices were implanted in the study population.None of the deaths were directly associated with medtronic product.Among all patients, adverse events included: antiarrhythmic medication for junctional ectopic tachycardia, ventricular tachycardia, or focal atrial tachycardia; peritoneal dialysis for low cardiac output; nitric oxide inhalation therapy for high right ventricular pressure; bacterial septicemia; transient phrenic nerve paresis; chylothorax; pleural effusion; pulmonary hemorrhage; multiple reintubations due to bronchial hyperreactivity or pulmonary edema; need for extracorporeal membrane oxygenation support (weaned successfully); reoperation due to conduit stenosis; reintervention; and rv-pa conduit explanted/replaced.Based on the available information, medtronic product may have been associated with the adverse events.No additional adverse patient effects or product performance issues were reported.
|